LM313 - Oto-Toxic Relationships

Friday, April 24, 2026

9:45 AM - 10:45 AM CST

Location: Room 221 CD

Earn 0.1 CEUs

Instructional Level: Fundamental

Lead Presenter(s)

Christopher Spankovich, AuD, PhD, MPH

Professor and Vice Chair of Research
University of Mississippi Medical Center
University of Mississippi Medical Center
Jackson, Mississippi

Disclosure(s): Financial - Medical Legal Consulting: Consultant (Ongoing); Nonfinancial - Board Member ACAE

PDF Handouts Slides

Abstract: Ototoxicity is a potentially preventable form of hearing loss. In this session we will review ototoxic drugs and mechanisms, evidence-based ototoxicity monitoring guidelines, and strategies to mitigate risk of ototoxicity.

Summary: Hundreds of drugs have been reported as having potential otologic/ototoxic side effects. In this session we will define ototoxicity and identify classes of drugs of interest and their proposed mechanisms of injury. Next, we will detail evidence-based ototoxicity monitoring considerations with recommendations for specific drugs. Finally, we will discuss strategies for minimizing ototoxicity including dose schedule, alternative agents, and ototherapeutics.

Brief Summary of Clinical Takeaways: The clinical takeaway of this session is an understanding of ototoxic drugs, evidence-based recommendations for monitoring, and otoprotective strategies. Audiologists should be able to recognize ototoxic drugs and have an evidence-based approach to monitoring to incorporate into thier practices.

Learning Objectives:

Upon completion, participants will be able to list ototoxic drugs.
Upon completion, participants will be able to describe ototoxicity monitoring approaches.
Upon completion, participants will be able to identify otoprotective strategies.